Center for Financial Planning, Inc.
Position in IBO — Impact Biomedical Inc.
CIK 1803557
SOUTHFIED, MI
Position in IBO
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$0
-$1 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
2 quarters on record
Position in Biotechnology
Healthcare · as of Jun 30, 2026Center for Financial Planning, Inc. holds $31,192 across 7 Biotechnology names. IBO ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
210 | $14,706 | |
| 2 | ADMA |
Adma Biologics, Inc.
|
1,500 | $12,555 | |
| 3 | BEAM |
Beam Therapeutics Inc.
|
50 | $1,716 | |
| 4 | MNKD |
Mannkind Corp
|
354 | $1,508 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
10 | $545 | |
| 6 | EDIT |
Editas Medicine, Inc.
|
50 | $162 | |
| 7 | IBO |
Impact Biomedical Inc.
This page
|
0 | $0 |
All Filings in IBO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0 | 0 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $1 | 0 | Shares | Sole | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||